Chronix Nabs $1.8M in Series E Funding

The company is using the financing from existing and new backers to develop its multi-use apoptic DNA biomarker-based disease tests.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories